Replies to post #133622 on Biotech Values

[DewDiligence]

If all six [FoB’s] are included, $61 million total [in up-front payments].

MNTA has so much cash—and more of it accruing every day that m-enox remains the sole Lovenox generic—that the up-front amounts are probably the least consequential aspect of the MNTA-BAX deal from an investment standpoint.